Related references
Note: Only part of the references are listed.Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice
Paul T. Martin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Oculopharyngeal muscular dystrophy: A polyalanine myopathy
Bernard Brais
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2009)
A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis
Brett M. Morrison et al.
EXPERIMENTAL NEUROLOGY (2009)
Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing
H. Y. Chen et al.
GENE THERAPY (2009)
Hydrodynamic Limb Vein Injection of Adeno-Associated Virus Serotype 8 Vector Carrying Canine Myostatin Propeptide Gene into Normal Dogs Enhances Muscle Growth
Chunping Qiao et al.
HUMAN GENE THERAPY (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
Yi Lai et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
Hans A. Heemskerk et al.
JOURNAL OF GENE MEDICINE (2009)
Truncated dystrophins can influence neuromuscular synapse structure
Glen B. Banks et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Design of Phosphorodiamidate Morpholino Oligomers ( PMOs) for the Induction of Exon Skipping of the Human DMD Gene
Linda J. Popplewell et al.
MOLECULAR THERAPY (2009)
SINGLE MUSCLE FIBER CONTRACTILE PROPERTIES IN ADULTS WITH MUSCULAR DYSTROPHY TREATED WITH MYO-029
Lisa S. Krivickas et al.
MUSCLE & NERVE (2009)
INHIBITION OF MYOSTATIN WITH EMPHASIS ON FOLLISTATIN AS A THERAPY FOR MUSCLE DISEASE
Louise R. Rodino-Klapac et al.
MUSCLE & NERVE (2009)
Disease Rescue and Increased Lifespan in a Model of Cardiomyopathy and Muscular Dystrophy by Combined AAV Treatments
Carmen Vitiello et al.
PLOS ONE (2009)
Adeno-Associated Virus-8-Mediated Intravenous Transfer of Myostatin Propeptide Leads to Systemic Functional Improvements of Slow but Not Fast Muscle
Keith Foster et al.
REJUVENATION RESEARCH (2009)
A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy
Kathryn R. Wagner et al.
ANNALS OF NEUROLOGY (2008)
Investigating the pathology of Emery-Dreifuss muscular dystrophy
Susan C. Brown et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Molecular signatures of Emery-Dreifuss muscular dystrophy
Matthew A. Wheeler et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Assessment of the feasibility of exon 45-55 multiexon skipping for duchenne muscular dystrophy
Laura van Vliet et al.
BMC MEDICAL GENETICS (2008)
Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice
Basma F. Benabdallah et al.
CELL TRANSPLANTATION (2008)
Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1
Perla Kaliman et al.
CELLULAR SIGNALLING (2008)
Combining stem cells and exon skipping strategy to treat muscular dystrophy
Mirella Meregalli et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice
Masashi Nakatani et al.
FASEB JOURNAL (2008)
Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass
N. Kinouchi et al.
GENE THERAPY (2008)
Construction and analysis of compact muscle-specific promoters for AAV vectors
B. Wang et al.
GENE THERAPY (2008)
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice
Michela Alessandra Denti et al.
HUMAN GENE THERAPY (2008)
Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy
Juan Li et al.
HUMAN GENE THERAPY (2008)
Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice
Brian Bostick et al.
HUMAN GENE THERAPY (2008)
Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice
Chunping Qiao et al.
HUMAN GENE THERAPY (2008)
Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy
En Kimura et al.
HUMAN MOLECULAR GENETICS (2008)
Myostatin directly regulates skeletal muscle fibrosis
Zhao Bo Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Lentivirus mediated HO-1 gene transfer enhances myogenic precursor cell survival after autologous transplantation in pig
Thomas Laumonier et al.
MOLECULAR THERAPY (2008)
Genetic complementation of human muscle cells via directed stem cell fusion
Manuel A. F. V. Goncalves et al.
MOLECULAR THERAPY (2008)
Transduction of full-length dystrophin to multiple skeletal muscles improves motor performance and life span in utrophin/dystrophin double knockout mice
Ryoko Kawano et al.
MOLECULAR THERAPY (2008)
Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice
Guy L. Odom et al.
MOLECULAR THERAPY (2008)
A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner
Arkasubhra Ghosh et al.
MOLECULAR THERAPY (2008)
Codon and mRNA Sequence Optimization of Microdystrophin Transgenes Improves Expression and Physiological Outcome in Dystrophic mdx Mice Following AAV2/8 Gene Transfer
Helen Foster et al.
MOLECULAR THERAPY (2008)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
Natee Jearawiriyapaisarn et al.
MOLECULAR THERAPY (2008)
Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C
Sasha Bogdanovich et al.
MUSCLE & NERVE (2008)
PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle
Cesare Gargioli et al.
NATURE MEDICINE (2008)
Calpain 3, the gatekeeper of proper sarcomere assembly, turnover and maintenance
Jacques S. Beckmann et al.
NEUROMUSCULAR DISORDERS (2008)
Muscular dystrophies due to glycosylation defects
Francesco Muntoni et al.
NEUROTHERAPEUTICS (2008)
Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies
Volker Straub et al.
NEUROTHERAPEUTICS (2008)
Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors
Amanda M. Haidet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles
M. Bouchentouf et al.
GENE THERAPY (2008)
Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice
C-M Liu et al.
GENE THERAPY (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice
Rachid Benchaouir et al.
CELL STEM CELL (2007)
Autologous transplantation of SM/C-2.6+ satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice
Madoka Ikemoto et al.
MOLECULAR THERAPY (2007)
Successful compensation for dystrophin deficiency by a helper-dependent adenovirus expressing full-length utrophin
Jatinderpal R. Deol et al.
MOLECULAR THERAPY (2007)
Morpholino oligomer -: Mediated Exon skipping averts the onset of dystrophic pathology in the mdx mouse
Sue Fletcher et al.
MOLECULAR THERAPY (2007)
Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo
H. M. Moulton et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript
Steve D. Wilton et al.
MOLECULAR THERAPY (2007)
AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not α-sarcoglycan deficiency
M. Bartoli et al.
GENE THERAPY (2007)
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells
Arianna Dellavalle et al.
NATURE CELL BIOLOGY (2007)
Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase
S. P. Quenneville et al.
GENE THERAPY (2007)
Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63 % of patients with Duchenne muscular dystrophy
Christophe Beroud et al.
HUMAN MUTATION (2007)
Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle
Maja Z. Salva et al.
MOLECULAR THERAPY (2007)
Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: Human cells and primate models
Simon P. Quenneville et al.
MOLECULAR THERAPY (2007)
Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
Guy L. Odom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of Exon 51 during dystrophin Pre-mRNA splicing in human muscle
V. Arechavala-Gomeza et al.
HUMAN GENE THERAPY (2007)
First test of a high-density injection protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up
Daniel Skuk et al.
NEUROMUSCULAR DISORDERS (2007)
Autologous transplantation of muscle-derived CD133(+) stem cells in Duchenne muscle patients
Y. Torrente et al.
CELL TRANSPLANTATION (2007)
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
Maurilio Sampaolesi et al.
NATURE (2006)
Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition
Yutaka Ohsawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Electrotransfer into skeletal muscle for protein expression
C. Trollet et al.
CURRENT GENE THERAPY (2006)
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
G. C. Minetti et al.
NATURE MEDICINE (2006)
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
G. McClorey et al.
GENE THERAPY (2006)
Induced dystrophin exon skipping in human muscle explants
G. McClorey et al.
NEUROMUSCULAR DISORDERS (2006)
Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass
Thomas R. Magee et al.
JOURNAL OF GENE MEDICINE (2006)
Exploring the frontiers of therapeutic dxon skipping for Duchenne muscular dystrophy by double targeting within one or multiple dxons
Annemieke Aartsma-Rus et al.
MOLECULAR THERAPY (2006)
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Paul Gregorevic et al.
NATURE MEDICINE (2006)
Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy
Y Takeshima et al.
PEDIATRIC RESEARCH (2006)
Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex
LM Judge et al.
JOURNAL OF CELL SCIENCE (2006)
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model
MA Denti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Differential cellular responses to exogenous DNA in mammalian cells and its effect on oligonucleotide-directed gene modification
O Igoucheva et al.
GENE THERAPY (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Y Lai et al.
NATURE BIOTECHNOLOGY (2005)
Effective repetitive dystrophin gene transfer into skeletal muscle of adult mdx mice using a helper-dependent adenovirus vector expressing the coxsackievirus and adenovirus receptor (CAR) and dystrophin
Y Uchida et al.
JOURNAL OF GENE MEDICINE (2005)
Myostatin propeptide-mediated amelioration of dystrophic pathophysiology
S Bogdanovich et al.
FASEB JOURNAL (2005)
Gene transfer into skeletal muscle using novel AAV serotypes
JP Louboutin et al.
JOURNAL OF GENE MEDICINE (2005)
Strand bias in oligonucleotide-mediated dystrophin gene editing
C Bertoni et al.
HUMAN MOLECULAR GENETICS (2005)
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
QL Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Transduction of satellite cells after prenatal intramuscular administration of lentiviral vectors
TC MacKenzie et al.
JOURNAL OF GENE MEDICINE (2005)
Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells
D Skuk et al.
MOLECULAR THERAPY (2004)
Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD)
T Athanasopoulos et al.
GENE THERAPY (2004)
Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers):: target sequence optimisation using oligonucleotide arrays
IR Graham et al.
JOURNAL OF GENE MEDICINE (2004)
Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles
MJ Molnar et al.
MOLECULAR THERAPY (2004)
Targeted exon skipping in transgenic hDMD mice:: A model for direct preclinical screening of human-specific antisense oligonucleotides
M Bremmer-Bout et al.
MOLECULAR THERAPY (2004)
Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency
M Tahara et al.
NATURE MEDICINE (2004)
A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs
JE Hagstrom et al.
MOLECULAR THERAPY (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Phase I study of dystrophin Duchenne/Becker plasmid-based gene therapy in muscular dystrophy
NB Romero et al.
HUMAN GENE THERAPY (2004)
Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells
GP Kobinger et al.
HUMAN GENE THERAPY (2003)
Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing
HJ Chao et al.
NATURE MEDICINE (2003)
Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle
BL Gebski et al.
HUMAN MOLECULAR GENETICS (2003)
Antisense-mediated redirection of mRNA splicing
M Vacek et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Novel therapies for Duchenne muscular dystrophy
R Kapsa et al.
LANCET NEUROLOGY (2003)
Functional improvement of dystrophic muscle by myostatin blockade
S Bogdanovich et al.
NATURE (2002)
Oligonucleotide-mediated gene repair at DNA level: the potential applications for gene therapy
CM Liu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
An algorithm for finding protein-DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments
XS Liu et al.
NATURE BIOTECHNOLOGY (2002)
Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Δ48-50 DMD cells
FG De Angelis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Regulation of myostatin activity and muscle growth
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Gene correction of the apolipoprotein (apo) E2 phenotype to wild-type apoE3 by in situ chimeraplasty
AD Tagalakis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates
GF Zhang et al.
HUMAN GENE THERAPY (2001)
Targeted gene correction by small single-stranded oligonucleotides in mammalian cells
O Igoucheva et al.
GENE THERAPY (2001)
Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing
SG Mansfield et al.
GENE THERAPY (2000)
Share Paper
